Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2014, Article ID 581706, 10 pages
http://dx.doi.org/10.1155/2014/581706
Research Article

Breast Cancer with Neoductgenesis: Histopathological Criteria and Its Correlation with Mammographic and Tumour Features

1Department of Surgical Sciences, Uppsala University, 751 85 Uppsala, Sweden
2Department of Pathology, Örebro University, 701 85 Örebro, Sweden
3Department of Pathology, Falun Central Hospital, 791 82 Falun, Sweden
4Department of Research Oncology, King’s College London, London SE1 9RT, UK
5Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden
6Department of Oncology, Helsinki University Central Hospital, 00029 Helsinki, Finland
7Department of Radiology, Oncology and Radiation Science, Uppsala University, 751 85 Uppsala, Sweden
8Department of Surgery, Falun Central Hospital, 791 82 Falun, Sweden
9Department of Surgery, Uppsala Academic Hospital, 751 85 Uppsala, Sweden

Received 12 May 2014; Accepted 9 September 2014; Published 8 October 2014

Academic Editor: Zsuzsanna Kahán

Copyright © 2014 Wenjing Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Tabar, H.-H. Tony Chen, M. F. Amy Yen et al., “Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma: suggestions for the reconsideration of current therapeutic practice and the TNM classification system,” Cancer, vol. 101, no. 8, pp. 1745–1759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Tabar, T. Tot, and P. Dean, Breast Cancer: Early Detection with Mammography: Crushed Stone-Like Calcifications: The Most Frequent Malignant Type, Thieme Medical Publishers, 2007.
  3. G. Hermann, R. J. Keller, S. Drossman et al., “Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation,” Canadian Association of Radiologists Journal, vol. 50, no. 4, pp. 235–240, 1999. View at Google Scholar · View at Scopus
  4. T. Tot and L. Tabár, “Mammographic-pathologic correlation of ductal carcinoma in situ of the breast using two- and three-dimensional large histologic sections,” Seminars in Breast Disease, vol. 8, no. 3, pp. 144–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Muggerud, M. Hallett, H. Johnsen et al., “Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer,” Molecular Oncology, vol. 4, no. 4, pp. 357–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Wärnberg, R.-M. Amini, M. Goldman, and K. Jirström, “Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast,” Histopathology, vol. 53, no. 6, pp. 642–649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Jirström, A. Ringberg, M. Fernö, L. Anagnostaki, and G. Landberg, “Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence,” British Journal of Cancer, vol. 89, no. 10, pp. 1920–1926, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Zhou, K. Jirström, C. Johansson et al., “Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study,” BMC Cancer, vol. 10, article 653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Wärnberg, H. Nordgren, L. Bergkvist, and L. Holmberg, “Tumour markers in breast carcinoma correlate with grade rather than with invasiveness,” British Journal of Cancer, vol. 85, no. 6, pp. 869–874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. P. E. Shrout, “Measurement reliability and agreement in psychiatry,” Statistical Methods in Medical Research, vol. 7, no. 3, pp. 301–317, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. http://www.statstodo.com/CohenKappa_Pgm.php.
  12. J. R. Landis and G. G. Koch, “The measurement of observer agreement for categorical data,” Biometrics, vol. 33, no. 1, pp. 159–174, 1977. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  13. T. Tot, “DCIS, cytokeratins, and the theory of the sick lobe,” Virchows Archiv, vol. 447, no. 1, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Chivukula, A. Domfeh, G. Carter, G. Tseng, and D. J. Dabbs, “Characterization of high-grade ductal carcinoma in situ with and without regressive changes: diagnostic and biologic implications,” Applied Immunohistochemistry & Molecular Morphology, vol. 17, no. 6, pp. 495–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. Pinder, C. Duggan, I. O. Ellis et al., “A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial,” British Journal of Cancer, vol. 103, no. 1, pp. 94–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Gnant, N. Harbeck, and C. Thomssen, “St. Gallen 2011: summary of the consensus discussion,” Breast Care, vol. 6, no. 2, pp. 136–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-R. Pradeep, A. Zeisel, W. J. Köstler et al., “Modeling invasive breast cancer: Growth factors propel progression of HER2-positive premalignant lesions,” Oncogene, vol. 31, no. 31, pp. 3569–3583, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Callahan and S. Hurvitz, “Human epidermal growth factor receptor-2-positive breast cancer: current management of early, advanced, and recurrent disease,” Current Opinion in Obstetrics and Gynecology, vol. 23, no. 1, pp. 37–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. P. Bagaria, P. S. Ray, J. Wang et al., “Prognostic value of basal phenotype in HER2-overexpressing breast cancer,” Annals of Surgical Oncology, vol. 19, no. 3, pp. 935–940, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Dandachi, C. Hauser-Kronberger, E. More et al., “Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins,” The Journal of Pathology, vol. 193, pp. 181–189, 2001. View at Google Scholar
  21. T. Jahkola, T. Toivonen, I. Virtanen et al., “Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence,” British Journal of Cancer, vol. 78, no. 11, pp. 1507–1513, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Jahkola, T. Toivonen, S. Nordling, K. von Smitten, and I. Virtanen, “Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion,” European Journal of Cancer, vol. 34, no. 11, pp. 1687–1692, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Goepel, J. Buchmann, R. Schultka, and H. Koelbl, “Tenascin—a marker for the malignant potential of preinvasive breast cancers,” Gynecologic Oncology, vol. 79, no. 3, pp. 372–378, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. G. K. Koukoulis, V. E. Gould, A. Bhattacharyya, J. E. Gould, A. A. Howeedy, and I. Virtanen, “Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications,” Human Pathology, vol. 22, no. 7, pp. 636–643, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Moch, J. Torhorst, U. Durmuller, G. E. Feichter, G. Sauter, and F. Gudat, “Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer,” Pathology Research and Practice, vol. 189, no. 5, pp. 510–514, 1993. View at Publisher · View at Google Scholar · View at Scopus